Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · Real-Time Price · USD
1.370
0.00 (0.00%)
At close: Jun 2, 2025, 4:00 PM
1.360
-0.010 (-0.73%)
After-hours: Jun 2, 2025, 5:37 PM EDT
Repare Therapeutics Market Cap
Repare Therapeutics has a market cap or net worth of $58.76 million as of June 2, 2025. Its market cap has decreased by -61.22% in one year.
Market Cap
58.76M
Enterprise Value
-64.09M
1-Year Change
-61.22%
Ranking
Category
Stock Price
$1.37
Market Cap Chart
Since June 19, 2020, Repare Therapeutics's market cap has decreased from $945.76M to $58.76M, a decrease of -93.79%. That is a compound annual growth rate of -42.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2025 | 58.76M | 5.52% |
| Dec 31, 2024 | 55.69M | -81.89% |
| Dec 29, 2023 | 307.55M | -50.18% |
| Dec 30, 2022 | 617.25M | -29.87% |
| Dec 31, 2021 | 880.19M | -30.20% |
| Dec 31, 2020 | 1.26B | 33.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.23B |
| Johnson & Johnson | 373.45B |
| AbbVie | 328.75B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 273.87B |
| Abbott Laboratories | 232.41B |
| AstraZeneca | 224.00B |
| Novartis AG | 223.92B |